 |
Humanized monoclonal immunoglobulin G1 antibody directed against human CD19 conjugated to SG3199 through a protease cleavable valine-alanine linker |
|---|---|
| Trade Name | |
| Orphan Indication | Diffuse Large B-cell Lymphoma |
| USA Market Approval | USA |
| USA Designation Date | 2017-06-08 00:00:00 |
| Sponsor | ADC Therapeutics SA;Route de la Corniche, 3B;Epalinges |
